UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns

The oncologist (Dayton, Ohio), 2021-09, Vol.26 (9), p.787-796

2021

Volltextzugriff (PDF)

A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker

BMC cancer, 2021-05, Vol.21 (1), p.510-510, Article 510

2021

Volltextzugriff (PDF)

Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: Phase 1 dose-escalation study

Investigational new drugs, 2014-12, Vol.32 (6), p.1181-1187

2014

Volltextzugriff (PDF)

Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS

Cancer treatment and research communications, 2022-01, Vol.32, p.100569-100569, Article 100569

2022

Volltextzugriff (PDF)

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

Frontiers in oncology, 2018-07, Vol.8, p.262-262

2018

Volltextzugriff (PDF)

Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma

European urology, 2017-10, Vol.72 (4), p.557-564

2017

Volltextzugriff (PDF)

Structural connectivity of Broca's area and medial frontal cortex

NeuroImage (Orlando, Fla.), 2010-10, Vol.52 (4), p.1230-1237

2010

Volltextzugriff (PDF)

Response to "Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?"

Journal of lower genital tract disease, 2019-01, Vol.23 (1), p.85-85

2019

Volltextzugriff (PDF)

264 Building Empowerment through FITness (BeFIT)

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.79-80

2024

Volltextzugriff (PDF)

Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes

Breast cancer research : BCR, 2024-07, Vol.26 (1), p.1-10, Article 118

2024

Volltextzugriff (PDF)

Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer

Nature communications, 2022-12, Vol.13 (1), p.7495-7495, Article 7495

2022

Volltextzugriff (PDF)

Inclusion of Sex and Gender in Emergency Medicine Research—A 2018 Update

Academic emergency medicine, 2019-03, Vol.26 (3), p.293-302

2019

Volltextzugriff (PDF)

Homologous Recombination Deficiency: Concepts, Definitions, and Assays

The oncologist (Dayton, Ohio), 2022-03, Vol.27 (3), p.167-174

2022

Volltextzugriff (PDF)

Concordance of HER2+ status by IHC/ISH and ERBB2 status by NGS in a real-world clinicogenomic database and analysis of outcomes in patients (pts) with metastatic breast cancer (mBC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1036-1036

2021

Volltextzugriff (PDF)

Rare BAP1 variant of unknown significance (VUS) and analysis of BAP1 codon 146 genomics: Potential germline and therapeutic implications

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10533-10533

2021

Volltextzugriff (PDF)

Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients

Journal of translational medicine, 2022-08, Vol.20 (1), p.370-370, Article 370

2022

Volltextzugriff (PDF)

ERBB2 copy number (CN) as a quantitative biomarker for real-world (RW) outcomes to anti-HER2 therapy in advanced gastroesophageal adenocarcinoma (adv GEA)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4045-4045

2021

Volltextzugriff (PDF)

Abstract P5-07-04: Comprehensive analysis of the gene rearrangements within 822 breast cancer brain metastases reveals an enrichment of cyclin dependent kinase 12 rearrangements in HER2-positive brain metastases

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-07-04

2022

Volltextzugriff (PDF)

Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix

The Journal of clinical investigation, 2020-09, Vol.130 (9), p.4704-4709

2020

Volltextzugriff (PDF)

Effect of Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology in an Urban Academic Clinic Setting

Journal of lower genital tract disease, 2018-10, Vol.22 (4), p.311-313

2018

Volltextzugriff (PDF)

Abstract PD9-09: High tumor mutational burden (>=10 mut/Mb) is enriched in specific breast cancer pathological subtypes

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD9-09-PD9-09

2021

Volltextzugriff (PDF)

The 27-gene IO score is associated with molecular features and response to immune checkpoint inhibitors (ICI) in patients with gastric cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4058-4058

2022

Volltextzugriff (PDF)

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

NPJ precision oncology, 2023-08, Vol.7 (1), p.76-76, Article 76

2023

Volltextzugriff (PDF)

Abstract PD4-09: Comprehensive assessment of the genomic landscape of breast cancer brain metastases reveals targetable alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD4-09-PD4-09

2022

Volltextzugriff (PDF)

The emerging target KRAS G12C in genitourinary malignancies

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.434-434

2020

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(107)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns

A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker

Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: Phase 1 dose-escalation study

Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma

Structural connectivity of Broca's area and medial frontal cortex

Response to "Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?"

264 Building Empowerment through FITness (BeFIT)

Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes

Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer

Inclusion of Sex and Gender in Emergency Medicine Research—A 2018 Update

Homologous Recombination Deficiency: Concepts, Definitions, and Assays

Concordance of HER2+ status by IHC/ISH and ERBB2 status by NGS in a real-world clinicogenomic database and analysis of outcomes in patients (pts) with metastatic breast cancer (mBC)

Rare BAP1 variant of unknown significance (VUS) and analysis of BAP1 codon 146 genomics: Potential germline and therapeutic implications

Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients

ERBB2 copy number (CN) as a quantitative biomarker for real-world (RW) outcomes to anti-HER2 therapy in advanced gastroesophageal adenocarcinoma (adv GEA)

Abstract P5-07-04: Comprehensive analysis of the gene rearrangements within 822 breast cancer brain metastases reveals an enrichment of cyclin dependent kinase 12 rearrangements in HER2-positive brain metastases

Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix

Effect of Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology in an Urban Academic Clinic Setting

Abstract PD9-09: High tumor mutational burden (>=10 mut/Mb) is enriched in specific breast cancer pathological subtypes

The 27-gene IO score is associated with molecular features and response to immune checkpoint inhibitors (ICI) in patients with gastric cancer

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing

Abstract PD4-09: Comprehensive assessment of the genomic landscape of breast cancer brain metastases reveals targetable alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors

The emerging target KRAS G12C in genitourinary malignancies

Suchergebnisse filtern